Wanhong Lu

机构：Sichuan University, First Affiliated Hospital of Xi'an Jiaotong University, First Hospital of Xi'an

发表论文 68 篇 · 总被引 985 次 · h-index 16

代表论文

• Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial (2024 · Nephrology Dialysis Transplantation · 被引 84)
• Obinutuzumab is effective for the treatment of frequently-relapsing/steroid-dependent minimal change disease in adults (2024 · Nephrology Dialysis Transplantation · 被引 11)
• Humoral immune responses primed by the alteration of gut microbiota were associated with galactose-deficient IgA1 production in IgA nephropathy (2024 · Frontiers in Immunology · 被引 10)
• Deciphering N-Glycosylation Dynamics of Serum Monoclonal Immunoglobulins in Multiple Myeloma via EThcD-sceHCD-MS/MS (2025 · Journal of Proteome Research · 被引 8)
• Hyperactivation of p53 contributes to mitotic catastrophe in podocytes through regulation of the Wee1/CDK1/cyclin B1 axis (2024 · Renal Failure · 被引 7)
• Additive Obinutuzumab Achieves High Remission Rates in Rituximab-Refractory Membranous Nephropathy (2025 · American Journal of Nephrology · 被引 6)